Evidence map›Paper›PMID 37042492›Full record

ArticleEndocrinology, diabetes & metabolism case reports2023

A family with type A insulin resistance syndrome caused by a novel insulin receptor mutation.

Osamu Horikawa, Satoshi Ugi, Tomofumi Takayoshi, Yasushi Omura, Maya Yonishi, Daisuke Sato, Yukihiro Fujita, Tomoya Fuke, Yushi Hirota, Wataru Ogawa and 1 more

Open access · goldAbstract read
In one paragraph

Article in Endocrinology, diabetes & metabolism case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Severe tolvaptan-associated hyperglycemia: a case report.Journal of medical case reports · 2025
    Article
  3. Severe Insulin Resistance Syndromes: Clinical Spectrum and Management.International journal of molecular sciences · 2025
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Osamu HorikawaDepartment of Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan.
Satoshi UgiDepartment of Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan.ORCID 0000-0001-5848-0666
Tomofumi TakayoshiDivision of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, Kobe, Japan.
Yasushi OmuraDepartment of Internal Medicine, Kohka Public Hospital, Kohka, Shiga, Japan.
Maya YonishiDepartment of Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan.
Daisuke SatoDepartment of Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan.
Yukihiro FujitaDepartment of Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan.
Tomoya FukeDepartment of Medicine, Saiseikai Shiga Hospital, Ritto, Shiga, Japan.
Yushi HirotaDivision of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, Kobe, Japan.
Wataru OgawaDivision of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, Kobe, Japan.
Hiroshi MaegawaDepartment of Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan.
Shiga University of Medical Science · JPKobe University · JPSaiseikai Shigaken Hospital · JPTaoka Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Summary: A 17-year-old boy was referred to our endocrinology clinic for a clinical investigation of hyperinsulinemia. An oral glucose tolerance test showed plasma glucose concentrations in the normal range. However, insulin concentrations were considerably elevated (0 min: 71 μU/mL; 60 min: 953 μU/mL), suggesting severe insulin resistance. An insulin tolerance test confirmed that he had insulin resistance. There was no apparent hormonal or metabolic cause, including obesity. The patient had no outward features of hyperinsulinemia, including acanthosis nigricans or hirsutism. However, his mother and grandfather also had hyperinsulinemia. Genetic testing showed that the patient (proband), his mother, and his grandfather had a novel p.Val1086del heterozygous mutation in exon 17 of the insulin receptor gene (INSR). Although all three family members have the same mutation, their clinical courses have been different. The onset of the mother's diabetes was estimated at 50 years, whereas the grandfather developed diabetes at 77 years. Learning points: Type A insulin resistance syndrome is caused by mutations in the insulin receptor (INSR) gene and results in severe insulin resistance. Genetic evaluation should be considered in adolescents or young adults with dysglycemia when an atypical phenotype, such as severe insulin resistance, or a relevant family history is observed. Clinical courses may differ even if the same genetic mutation is found in a family.

Identifiers

PMID37042492
PMCPMC10241234
OpenAlexW4365135436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.